|
[posting]61040530[/posting]\ud83d\udce2Why SLS Stock Could See A Big Bounce Today Sellas Life Sciences has been trading with a ton of volume lately. However, the price has been held down. So, what’s the deal? Well, it all has to do with a fund raise that was announced on June 18, 2019. The company raised about $13.5 million through the sale of newly issued common stock and warrants to purchase common stock. The truth of the matter is that warrants are known to hold the value of a stock down when exercised. That’s exactly what seems to have been happening with SLS stock. As investors exercised warrants, volume was high, but prices were low. However, the warrant pool is starting to dry up, and traders are starting to take note. As the warrant pool dries up, the pressure that has been leaning on the stock in recent sessions will be released. As such, the value of SLS shares could bounce upward, generating strong short term gains for those that time the move correctly (alphastocknews.com) |
|
| aus der Diskussion: | Sellas Life Sciences Group (ehemals Galena Biopharma) |
| Autor (Datum des Eintrages): | ToBeDoo (17.07.19 01:55:22) |
| Beitrag: | 2,523 von 2,941 (ID:61040752) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |